Michael Burkes Brophy - Apr 22, 2025 Form 4 Insider Report for Natera, Inc. (NTRA)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Apr 22, 2025
Transactions value $
-$321,809
Form type
4
Date filed
4/24/2025, 09:35 PM
Previous filing
Apr 22, 2025
Next filing
Apr 30, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Sale -$44.4K -308 -0.4% $144.30 76.2K Apr 22, 2025 Direct F1, F2
transaction NTRA Common Stock Sale -$87.6K -603 -0.79% $145.35 75.6K Apr 22, 2025 Direct F1, F3
transaction NTRA Common Stock Options Exercise +1.25K +1.65% 76.8K Apr 22, 2025 Direct F4
transaction NTRA Common Stock Sale -$74.6K -495 -0.64% $150.74 76.3K Apr 23, 2025 Direct F5
transaction NTRA Common Stock Sale -$85.5K -561 -0.74% $152.45 75.8K Apr 24, 2025 Direct F1
transaction NTRA Common Stock Sale -$29.6K -194 -0.26% $152.46 75.6K Apr 24, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -1.25K -33.33% $0.00 2.5K Apr 22, 2025 Common Stock 1.25K Direct F4, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2024.
F2 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.87 to $144.73 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.92 to $145.69 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
F5 The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on October 22, 2021.
F6 The RSUs vest over four years. 25% of the RSUs vested on October 22, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter.